GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance

Complete the form below to unlock access to ALL audio articles.
The eSensor Respiratory Viral Panel is designed to be a fast, easy-to-use molecular diagnostic test to provide accurate results while requiring less technologist time.
"The submission to the FDA of our eSensor Respiratory Viral Panel is an important step in GenMark's continued commitment to providing our customers with high quality in-vitro diagnostic molecular tests for use with our award winning eSensor XT-8 system," commented Hany Massarany, President and CEO of GenMark Diagnostics.